Recent Investment Analysts’ Ratings Changes for Teladoc Health (TDOC)

Several brokerages have updated their recommendations and price targets on shares of Teladoc Health (NYSE: TDOC) in the last few weeks:

• 4/29/2024 – Teladoc Health had its price target lowered by analysts at Wells Fargo & Company from $17.00 to $15.00. They now have an “equal weight” rating on the stock.
• 4/26/2024 – Teladoc Health had its price target lowered by analysts at Barclays PLC from $25.00 to $20.00. They now have an “overweight” rating on the stock.
• 4/26/2024 – Teladoc Health had its price target lowered by analysts at Oppenheimer Holdings Inc. from $26.00 to $21.00. They now have an “outperform” rating on the stock.
• 4/26/2024 – Teladoc Health had its price target lowered by analysts at Royal Bank of Canada from $25.00 to $18.00. They now have an “outperform” rating on the stock.
• 4/26/2024 – Teladoc Health had its price target lowered by analysts at Evercore ISI from $15.00 to $14.00. They now have an “in-line” rating on the stock.
• 4/26/2024 – Teladoc Health had its price target lowered by analysts at TD Cowen from $16.00 to $15.00. They now have a “hold” rating on the stock.
• 4/26/2024 – Teladoc Health had its price target lowered by analysts at Stifel Nicolaus from $21.00 to $16.00. They now have a “hold” rating on the stock.
• 4/26/2024 – Teladoc Health had its “hold” rating reaffirmed by analysts at Needham & Company LLC.
• 4/26/2024 – Teladoc Health had its price target lowered by analysts at Canaccord Genuity Group Inc. from $28.00 to $25.00. They now have a “buy” rating on the stock.
• 4/5/2024 – Teladoc Health had its “hold” rating reaffirmed by analysts at Needham & Company LLC.
• 3/6/2024 – Teladoc Health had its price target lowered by analysts at Truist Financial Co. from $23.00 to $17.00. They now have a “hold” rating on the stock.

Teladoc Health Trading Down 4.8 %

Shares of Teladoc Health stock opened at $12.75 on Wednesday. The company has a current ratio of 3.54, a quick ratio of 3.47 and a debt-to-equity ratio of 0.66. Teladoc Health, Inc. has a 1 year low of $12.65 and a 1 year high of $30.41. The firm has a market capitalization of $2.16 billion, a PE ratio of -9.04 and a beta of 0.94. The firm’s 50 day moving average is $14.69 and its 200 day moving average is $17.67.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Thursday, April 25th. The health services provider reported ($0.49) EPS for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.02). The firm had revenue of $646.13 million for the quarter, compared to the consensus estimate of $637.31 million. Teladoc Health had a negative net margin of 8.90% and a negative return on equity of 10.11%. The business’s revenue was up 2.7% compared to the same quarter last year. During the same period last year, the company posted ($0.37) EPS. Equities research analysts forecast that Teladoc Health, Inc. will post -1.06 earnings per share for the current fiscal year.

Insider Transactions at Teladoc Health

In other Teladoc Health news, EVP Andrew Turitz sold 6,190 shares of the stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $14.52, for a total value of $89,878.80. Following the sale, the executive vice president now directly owns 39,429 shares in the company, valued at approximately $572,509.08. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Teladoc Health news, EVP Andrew Turitz sold 6,190 shares of the business’s stock in a transaction on Monday, March 4th. The shares were sold at an average price of $14.52, for a total value of $89,878.80. Following the completion of the sale, the executive vice president now directly owns 39,429 shares of the company’s stock, valued at $572,509.08. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Arnnon Geshuri sold 7,500 shares of the firm’s stock in a transaction on Monday, March 25th. The stock was sold at an average price of $15.06, for a total transaction of $112,950.00. Following the completion of the sale, the insider now directly owns 38,470 shares in the company, valued at approximately $579,358.20. The disclosure for this sale can be found here. Insiders sold a total of 135,441 shares of company stock worth $2,038,251 in the last quarter. Insiders own 0.95% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. Commonwealth Equity Services LLC increased its holdings in shares of Teladoc Health by 5.7% in the 3rd quarter. Commonwealth Equity Services LLC now owns 80,934 shares of the health services provider’s stock worth $1,505,000 after buying an additional 4,344 shares during the last quarter. Robeco Institutional Asset Management B.V. raised its holdings in shares of Teladoc Health by 49.4% in the third quarter. Robeco Institutional Asset Management B.V. now owns 453,861 shares of the health services provider’s stock valued at $8,437,000 after acquiring an additional 149,976 shares in the last quarter. Raymond James & Associates lifted its position in shares of Teladoc Health by 0.9% in the 3rd quarter. Raymond James & Associates now owns 228,238 shares of the health services provider’s stock worth $4,243,000 after purchasing an additional 2,029 shares during the period. Mackenzie Financial Corp lifted its holdings in Teladoc Health by 83.7% during the third quarter. Mackenzie Financial Corp now owns 30,843 shares of the health services provider’s stock worth $570,000 after buying an additional 14,050 shares during the period. Finally, Allspring Global Investments Holdings LLC raised its holdings in Teladoc Health by 8.8% in the third quarter. Allspring Global Investments Holdings LLC now owns 50,903 shares of the health services provider’s stock worth $946,000 after purchasing an additional 4,129 shares in the last quarter. 76.82% of the stock is currently owned by institutional investors.

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.